ConvaTec Group’s (CTEC) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft restated their buy rating on shares of ConvaTec Group (LON:CTEC) in a report published on Wednesday morning,Digital Look reports. Deutsche Bank Aktiengesellschaft currently has a GBX 315 price objective on the stock.

Several other analysts have also issued reports on the stock. Jefferies Financial Group restated a “buy” rating and issued a GBX 300 price objective on shares of ConvaTec Group in a report on Wednesday. Berenberg Bank reiterated a “buy” rating and set a GBX 340 price target on shares of ConvaTec Group in a research report on Tuesday, April 21st. Peel Hunt reissued an “add” rating and issued a GBX 270 price target on shares of ConvaTec Group in a research note on Tuesday. Citigroup decreased their price objective on shares of ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating on the stock in a report on Monday, May 18th. Finally, UBS Group reaffirmed a “buy” rating and set a GBX 375 price objective on shares of ConvaTec Group in a research report on Monday, May 18th. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of GBX 306.

ConvaTec Group Stock Up 2.5%

CTEC stock opened at GBX 232.40 on Wednesday. ConvaTec Group has a one year low of GBX 193 and a one year high of GBX 259.30. The firm has a market cap of £4.54 billion, a PE ratio of 27.02, a PEG ratio of 0.93 and a beta of 0.77. The firm’s 50 day moving average price is GBX 213.38 and its 200-day moving average price is GBX 221.01. The company has a debt-to-equity ratio of 121.83, a quick ratio of 0.96 and a current ratio of 1.93.

Insider Activity at ConvaTec Group

In related news, insider Tobias Hestler acquired 50,000 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were acquired at an average price of GBX 226 per share, with a total value of £113,000. Also, insider Jonny Mason acquired 50,000 shares of the business’s stock in a transaction dated Tuesday, May 26th. The shares were bought at an average cost of GBX 201 per share, for a total transaction of £100,500. Company insiders own 0.98% of the company’s stock.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.